CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Data Shows Growing Number of Native American Tribal Cannabis Business Owners

As more states continue to legalize adult-use cannabis, we’re witnessing a growing trend surrounding ownership of cannabis businesses — namely that Native American tribes are investing in cannabis with tribal-owned stores becoming increasingly more common in recent years. According to data published in MJBizDaily, the number of tribally owned retailers has grown by roughly 25% since January 2023. As of May 2024, there are 57 tribally owned dispensaries, both medical and adult-use, throughout nine states. With legal adult-use cannabis becoming more commonplace throughout the country, tribes are entering the industry to diversify their economies and boost revenue.  Though legal cannabis also carries unique benefits for tribes, as a way to assert their sovereignty and seize the first-to-market advantage in newly legal states, as explained by guest columnist Matthew Klas, a senior associate with Minneapolis-based national consulting firm KlasRobinson Q.E.D. specializing in economic development on tribal lands. There are 574 Native American tribes recognized by the U.S. government, with roughly 350 falling in the lower 48 states. Sovereign nations may have their own laws that differ from state laws, sometimes more restrictive — like cannabis sales and use bans even within states that have enacted recreational reform — or sometimes offering more leniency than state law. While many of the stores are on tribal lands, not all are. Tribes are currently operating businesses in nine states: California, Michigan, Minnesota, Nevada, New Mexico, New York, North Carolina, South Dakota and Washington.  The data found that the average size of tribal cannabis stores is about 4,300 square feet, ranging from stores with less than 1,000 square feet to complexes spanning more than 10,000.  Washington state has the most tribal retailers and the most tribes operating shops, at 23 stores operated by 18 tribes. Nevada is second, with 10 tribal stores owned by eight different tribes. Most of these tribally owned shops are located within markets with legal recreational cannabis, though there are exceptions. For example, there are two tribally owned dispensaries in South Dakota and one in North Carolina that currently offer medical cannabis exclusively.  The data does not include businesses owned by individual tribal members, rather than a tribal government. We can look at Minnesota to see how tribal business owners are able to get a jumpstart on a budding industry, as lawmakers in the state legalized adult-use cannabis last year but have yet to begin licensing retail establishments.  It’s unlikely that the marketplace will open until at least 2025, leaving a gap between legalization and the opening of the regulated market. However, tribal-owned dispensaries are helping to bridge that gap as two dispensaries owned by the Red Lake Nation and White Earth Nation are currently serving adult-use customers with plans to open additional facilities in the future. According to Minnesota’s recreational cannabis law, the governor can negotiate compacts with state tribes if they seek to take advantage of cannabis sales, but it also “acknowledges the sovereign right of Minnesota Tribal governments” to regulate their cannabis industries even without a compact. Red Lake and other tribes can also operate dispensaries outside of reservations through compacts negotiated with the governor’s administration. “We see this as a resource not only to reduce harm, but to also bring in resources to help our people recover,” said Red Lake Nation Tribal Secretary Sam Strong. The Mille Lacs Band of Ojibwe is also constructing a 50,000 square foot cannabis cultivation facility near Minneapolis, which is larger than any state-licensed grow operations, that will focus on seed-to-sale operations and could be a crucial part of the state’s recreational industry upon full launch. Similarly, New York has witnessed numerous delays in the launch of its recreational cannabis market, but three tribally owned stores have opened in the state since 2023. With Minnesota’s specific laws designed to leave room for tribal sovereignty, Klas says that the Minnesota market will be “particularly interesting” to watch in the future, adding that, “Minnesota could see some of the fastest growth of tribal cannabis businesses in the United States.” The full column can be found here.

https://hightimes.com/

The Hottest Legal THCA Snow Caps

Maybe you’ve been hearing about THCA Snow Caps aka THCA Snowballs, which are slowly becoming a very in-demand product on the hemp market, as more and more customers are gravitating toward high-potency flower products.  THCA snowcaps, also known as snowcaps, are named after their frosty appearance, and they are extremely potent, making them great for those who crave an extra-strong THCA kick. If you’re curious to know what THCA snowcaps can offer to hemp enthusiasts, stick around folks, because we’ll be explaining what they are, how they’re made, and how to grab the highest-quality snowballs that are out there today. And if you want to try THCA Snow Caps use our code HIGHTIMES25 for 25% off while being treated to fast and free shipping here.  First up, we want to shed light on exactly what THCA Snowcaps are.  We’re all familiar with THCA flower, which is hemp-derived flower buds that are bred carefully to produce a high concentration of THCA.  THCA, of course, is tetrahydrocannabinolic acid, aka delta 9’s raw form, which turns into delta 9 when it’s exposed to a specific temperature, which can be achieved through smoking, vaping, or cooking/baking with the flower buds. THCA flower is hugely popular because it’s chemically identical to weed, while being protected under federal law.  THCA snowballs take the concept to a new level, by coating each high-THCA flower bud in THCA diamond dust. THCA diamonds are purified/ THCA cannabinoid, which naturally takes on a crystalline form.  Odorless, colorless, and flavorless, THCA diamonds are pure THCA, meaning that their potency is high, and they, like the flower, actually provide delta 9 THC once heated. THCA diamond dust is the result of crushing the diamonds into a fine power.  By coating each bud in this powder, you get a flower bud that has an outstanding THCA concentration – up to 80%, in fact, while traditional flower buds rarely exceed 30%. THCA snow caps are used interchangeably with THCA flower buds.  You can smoke them, vape them, bake with them, or what have you, with no difference between how they’re utilized vs. standard flower.  And, they’re cultivated just like regular flower, since again, the only difference is that THCA snowcaps are rolled in diamond dust after the curing process is complete. With that being said, THCA Snow Caps, like THCA flower, can vary in terms of how they’re cultivated.  All THCA flower comes from industrial hemp, which can be grown indoors, outdoors, or in a greenhouse, with all kinds of different techniques used to ensure the best outcome of the flower buds themselves. Exotic THCA snowcaps come from exotic THCA flower buds, and this distinctive classification speaks to the exceptional quality and high THCA percentage that customers are in for.  In order to be considered exotic, THCA flower must have the following qualities: THCA snowcaps, therefore, are going to be a step above the rest, as this is the highest caliber of quality that you can find.  It should be pointed out that most exotic THCA flower is grown indoors, as it’s easier to control the outcome of the buds through manipulation of light, temperature, and so on, all of which play a major role in the development of the desirable cannabinoids and terpenes in the plant. Again, THCA Snowballs are a high-potency product, which means that they’re best for someone who already has a good THC tolerance.  Because THCA converts into delta 9 THC when flower is consumed, the high you can get from using snowballs is pretty intense.  For those who find that regular flower is too mild for them, that’s a good thing. Also, remember, THCA snowcaps offer tremendous value.  They’re so powerful that a little goes a long way, basically stretching out your supply so you can go longer between having to reup. You will see THCA snowcaps confused for THCA moonrocks pretty frequently, but these are ultimately two different products.  THCA moonrocks are THCA flower buds infused with THCA distillate and covered in kief, which is a full-spectrum powder that naturally falls off of the trichomes of the buds.  This is different from THCA snowcaps, which are more potent, as they’re covered in a thick layer of pure THCA diamond dust.   THCA Snow Caps are the next big thing on the hemp market, and Bloomz has you covered with outstanding, high-quality and well-crafted THCA Snowballs, combining the most exceptional flower with pure THCA diamonds for max potency and max satisfaction.   Bloomz has over 4,000 five-star customer reviews, over 100,000 loyal customers, fast and free shipping, 24/7 customer service, and best of all the strongest THCA Snow Caps on the market with flower above 30% potency. It  does not get much better than that! You will be able to enjoy boutique-level and indoor-grown THCA snowballs, available in 3.5g and 7g options, which are made using organically homegrown buds that’re already high in tetrahydrocannabinolic acid, rolled in Bloomz signature 99% pure THCA diamond dust.  The extravagant potency of these snowcaps means that you’re in for a high that’s out of this world.   Best of all you get to explore all 4 strains while finding satisfaction on a whole new level – 2 “standard” and 2 “exotic” strains. THCA Snowcaps are Indoor High Percentage THCA Flower covered in potent and pure THCA Isolate.  Ideal for connoisseurs seeking the highest quality and intensity, these THCA snowcaps deliver a powerful experience in every puff.  You can truly elevate your sessions with the purest, most potent THCA SnowCaps on the market. MAC is a 50/50 hybrid short for Miracle Alien Cookies, with roughly 24% THCA.  Its carefree high is legendary, offering a feeling of relief in the mind and body, as you stay calm yet uplifted throughout the experience.  It’s a dank strain with pungent notes of diesel, citrus, and earthiness. A cross between Pineapple Express and OG Kush, Pineapple OG is a superstar of a cultivar, with about 26% THCA, and a 70% sativa orientation.  It’s a sociable strain that can make you feel chatty, euphoric, and like all is right in the world, and can relax the body without sedating you. This is Exotic THCA Flower used with these snowcaps in order to create the strongest and best batches of farm-grown THCA Flower around.  Combined with pure THCA Isolate, this Snowcaps THCA Flower is the top choice on the hemp marketplace. Sour Diesel is a 90% sativa-dominant hybrid that’s legendary, with its powerful notes of diesel and sour lemons, and its ability to offer up a major boost in energy, chattiness, and creativity.   Mendo Purps is a 60/40 sativa-dominant hybrid with roughly 22% THC, known for its ability to give you fits of giggles, acting as the perfect social strain for when you want to partake with your friends.  Bloomz THCA Flower Offers High Potency for Maximum Satisfaction! Overall, if you’re looking to get as high as possible off of THCA Snowcaps , then you have found your new favorite flower brand: Bloomz. Here, you can explore 2 distinctive product lines, both offering high levels of THCA that you know and love.   Head on over to Bloomz and check out their selection, keeping in mind that their Gold Line Snowcaps delivers the highest THCA levels you will discover on the hemp marketplace today and don’t forget to use the code HIGHTIMES25 for 25% off while being treated to fast shipping so that you can take advantage of this THCA Snow Caps. To Buy Brand New THCA Snowcaps Click Here

https://hightimes.com/

Martha’s Vineyard Dispensary Sues To Allow Delivery of Cannabis From Massachusetts Mainland

Martha’s Vineyard is an island off the coast of Massachusetts that’s known for its 23 miles of scenic hills and beaches. It’s a popular destination for summer vacationers enjoying the quaint Victorian architecture, as of July 2021, it had one medical cannabis dispensary (Fine Fettle Dispensary) which until recently was also the only cannabis cultivator on the island, in addition to one adult-use only dispensary (Island Time) which opened in August 2021. The cost of living is high in Martha’s Vineyard, and for business owners, it’s expensive to transport goods from the mainland across the Vineyard Sound (aka the stretch of ocean that sits between Cape Cod, Massachusetts and Martha’s Vineyard). For cannabis businesses, it’s also federally illegal to have cannabis products delivered from the mainland. Recently, the owner of Island Time, Geoff Rose, filed a lawsuit against the Massachusetts Cannabis Control Commission (CCC) regarding a rule that bans him from transporting cannabis by boat from the mainland. “For more than 11 years, my efforts have centered on providing safe and responsible cannabis to local residents and visitors alike,” Rose explained to the Vineyard Gazette. “I’m hoping that the court will mandate the commission take immediate action to allow us to transport the product from the mainland.” He added that the rule puts a burden on him as a business owner, since he can only sell cannabis that he cultivates on the island. This rule was put in place because of state and federal regulations about cannabis being moved across water or through airspace. Rose’s lawsuit claims that Vineyard Sound is still within the state’s jurisdiction. Earlier in May, the other dispensary and sole owner of the island’s only cannabis production license, Fine Fettle Dispensary, announced that it would be shutting down operations. “Very sadly, we have had to make the decision to slow down and then ultimately shut down operations on the Vineyard,” Fine Fettle Dispensary president Benjamin Zachs said to the Vineyard Gazette. Up until now, Island Time obtained all of its cannabis products from Fine Fettle Dispensary. To bypass this new change, Rose inquired with the CCC about ordering cannabis from the mainland, but the CCC rejected the idea, stating the limitations of violating federal law. In March, Rose had cannabis delivered by boat anyway, and the products were delivered on a Steamship Authority ferry, which is run by the U.S. Coast Guard and falls under federal authority. The unnamed supplier that Rose worked with later received a warning. He was told not to sell the products delivered via ferry, but that order was later lifted, and Rose was able to sell out of all of the products. Last week, Rose officially closed his dispensary and told customers that he is unable to receive any new product. “We will reopen when we are able to source products from the mainland,” Rose wrote. “I am hopeful for a resolution soon that will result in more products, choices, and value for you, our valued customer.”  Through the lawsuit, Rose is calling for the Suffolk County Superior Court to grant an injunction so that he can have cannabis delivered to the island. “[Island Time] is being starved to death by the Commission’s arbitrary, unreasonable and inconsistent policy against transporting marijuana and marijuana products over state territorial waters,” Rose explained, warning that his employees will seek other jobs if his business is closed for two weeks or more. On May 9, the CCC met to discuss the situation and potential courses of action. Not only would the lack of delivery cause Island Time to close permanently, but it would also leave medical cannabis patients living on the island without any access to medicine. “If we do nothing, you are going to have 234 patients with no medical access on the Island. That’s the reality of it,” said commissioner Kimberly Roy. Additionally, local resident Sally Rizzo filed an affidavit with the supreme court as well. “If I have no retail source of marijuana for my medical needs, my quality of life will suffer significantly,” she wrote. “I am unwilling—and should not be compelled—to risk purchasing untested marijuana from the illicit black market or purchasing marijuana from the Massachusetts mainland and transporting it to my home via the Steamship Authority to treat my documented medical condition.”  The commission itself didn’t provide any comment to Vineyard Gazette due to ongoing litigation, and only verified what the current law allows or doesn’t allow. “At this time, transportation of marijuana from the Commonwealth mainland to the island counties is not one of those accommodations,” the CCC stated. “To the extent permitted by law, the Commission has been discussing what may be possible in terms of extending additional accommodations to these licensees and will be scheduling a public meeting on Martha’s Vineyard within the next month to continue the conversation.”However, there are examples of products being delivered in some other states, such as New York, where ferry delivery over water is still counted as “ground transport.” Similar rules are in place for the delivery of cannabis from mainland California to Catalina Island.

https://hightimes.com/

Loud Talking

On the industrial outskirts of Oakland, California, tucked among the timeworn facades of warehouses and workshops, there’s a building entrance so nondescript it defies capture by photography—not only would you never notice it if you walked right past it, you wouldn’t even be able to see it if you were looking directly at it. Security is a paramount concern for cannabis businesses operating in “The Town,” and thanks to a serendipitous quirk of forced perspective and pre-war architecture, would-be bandits would have an easier time robbing the Hogwarts Express. This is ideal for a business trying to prevent unwelcome visitors, but much less so for a visiting journalist with a faulty sense of direction and a penchant for getting stoned before big interviews. In addition to being monstrously difficult to locate, once you step inside the building housing the corporate headquarters for James Loud Genetics, it gives the distinct impression of being—to quote Doctor Who—“bigger on the inside.” Blazing white, labyrinthine hallways with soaring ceilings (accented with large television monitors displaying high definition photos of different stages of the germination and tissue culture processes) connect to specialized, climate-controlled lab rooms, processing centers, and the plush lounge that serves as the studio for the James Loud Podcast. The titular host of that podcast, James Loud, is the founder and primary breeder at James Loud Genetics, a cannabis brand with deep roots in the pre-legalization weed game. Loud cracked his first seed in 1995, at the age of 14, and never looked back. Since then, he’s been exploring the bleeding edge of breeding techniques and technology, always staying true to his name and seeking the same Holy Grail—louder terps. The son of an engineer, Loud’s process has always been rooted in experimentation and innovation, and in the early days of his breeding career—when police helicopters were still actively scanning for the telltale heat signature of a commercial indoor cannabis grow—he responded with a technological solution. “I had a garage grow and we grew in octagons,” Loud says. “So we had vertical growing because we were worried about the footprint for the infrared from the helicopter. So we thought the footprint would be less so the heat signature would be less. And so we grew in these vertical grows where we had 26 plants per light, and they all grew towards that center light.” With that problem more or less solved, he settled into the business of actually growing cannabis, with varying degrees of success at first. “I really like Chem Dawg, so I grew some and it was just this wall of larf, it was terrible… outdoor it was phenomenal, indoor it was phenomenal in beds, but it wasn’t meant to be grown in a vertical system with a short veg [period], because it likes to stretch… The best thing for the octagon was GDP because it has a very short veg, so you can take something like GDP and veg it for seven to 10 days max and it still wouldn’t get to the light.” Loud has made a lifelong career from cannabis breeding, a decision that has taken him on a decades-long personal and professional journey, with stops around the world, from Colombia to Spain and beyond, and it all began in the pages of High Times. Like many of us who discovered cannabis before the advent of the internet, Loud found information and inspiration in the pages of this very magazine. One year after smoking his first joint at the age of 14, he read something that changed the trajectory of his entire life. “There was a High Times article when I was younger called ‘The Million-Dollar Grow Room,’ and that was my favorite article growing up… it changed my perspective on growing. We had closet grows and stuff like that, but that article put things in the realm of financial possibility,” he says, then smiles a bit sheepishly and admits, “And I just love High Times.” It’s a sentiment that’s proven to be mutual. James Loud Genetics has secured six High Times Cannabis Cup victories and was inducted into the High Times Seed Bank Hall of Fame in 2014. “Now I want to do ‘The Billion-Dollar Grow Room, and you can only do that with seeds,” Loud says. “We can make a billion dollars with seeds, no problem.” Considering the facility’s current production rate of roughly seven million seeds per year, $1 billion in revenue doesn’t seem that farfetched. His decision to dive headfirst into the risky, unregulated world of clandestine cultivation immediately led him down the path of innovation and experimentation. And once again, High Times played a role in his journey. “I got the Phototron, you know the ones that were in the back of High Times magazine,” he says with a smile. “The first time we grew, one of my friends fucked it up, he poured a whole gallon of fish emulsion and made the weed taste like salmon.” But, of course, things got better. “From the moment I got green bud, I loved the taste, the smells, everything about it including the high,” he says. “I was into all the different flavors, and that’s what’s always motivated my breeding.” Loud is an experienced cannabis connoisseur, and as a breeder he’s all too familiar with the fickle winds of fashion—this year’s superstar strain is tomorrow’s forgotten fad. So it’s not terribly shocking that he’s a bit of a classicist when it comes to the cultivars he’s passionate about; you’ll often hear him talking about the big names of yesteryear, like Super Silver Haze and Romulan with deep reverence and love. But there’s one particular cultivar whose haunting siren song still echoes tantalizingly to him from a not so distant past, and his eyes glisten with the light of a secret flame when he speaks her name: Cat Piss. “That needs to be mentioned in the article, how much I love Cat Piss,” he says. “That’s my desert island strain… it’s super nostalgic, we got it in the ’90s, like mid ’90s.”  For Loud, it was the first cultivar he ever smoked that passed what would become one of his go-to tests for gauging just how “loud” some weed is, the re-fire test. “It’s the first thing that I really remember that you smoked it down to the roach, and you fired it up the next day or even a week later and it still tasted like Cat Piss,” he says. Younger readers—those of you acclimated to cannabis with the sweet, approachable cake and candy flavors that dominate the current terpene landscape—may not realize that us late 20th century smokers once sought out weed that smelled like animal excretions. Both Skunk and Cat Piss were once towering giants in the minds of stoners seeking the strongest strain, highly prized for the intense intoxicating effects that came along with their raw pungency. Skunk is undeniably the biggest name that emerged from that era; an amalgamation of three classic landrace cultivars; Acapulco Gold, Colombian Gold, and Afghani, that smelled just like its name. But if Skunk and its direct descendants are like The Beatles and The Rolling Stones—universally acclaimed, widely known, and indelibly linked to the era that produced them—Cat Piss is more like Grand Funk Railroad; equally popular during their shared heyday, but criminally underrated and less widely remembered in the present time. Loud is setting out to change all that with a project that sits at the intersection of three of his overlapping passions, cannabis breeding, cannabis education, and Cat Piss, a documentary film about his breeding project to resurrect the strain with assistance from the original breeder, which he says will film “this year with a goal of releasing it later in the year.” During the day of my visit he’s preparing to interview Steve DeAngelo—founder and former CEO of the pioneering cannabis dispensary Harborside—for yet another documentary project collecting the oral history of cannabis. This on top of his recently published book, a groundbreaking textbook on the technical nuances of cannabis breeding and tissue culture, Cannabis Breeding: The Art and Science of Crafting Distinctive Cultivars. Loud is building a cannabis media empire, and his aspirations are on full display in the slick, professional design of his podcasting studio lounge, which is where the majority of our meeting takes place. It has an elaborate paint job that includes a graffiti-style mural, a large, backlit sign with his logo on it, a wall of Mason jars filled with seeds, a professional array of condenser mics on telescopic stands arranged at a chic wooden conference table surrounded by comfortable office chairs, and a fully stocked bar with everything from Japanese whiskey to cold Imperial ale in the fridge. The show itself is a fun, informative space where drug war veterans swap stories and give each other their flowers (and/or concentrates) while they’re still alive. The vibe is casual but serious, because everyone involved takes the craft of cannabis cultivation very seriously, but they also tend to be very serious smokers and the James Loud Podcast studio is definitely the smoking section at this facility. The conversation is wide ranging, often personal, and always entertaining. It’s like Charlie Rose meets Joe Rogan, only instead of asking his guests if they’ve ever smoked DMT, Loud asks them if they’ve ever smoked Cat Piss. At a time when the outlaw past of this industry seems increasingly at odds with the hyper-regulated confines of its present and future, Loud provides a living bridge from past to present and a clear vision for the future. “We’re slowly but surely becoming tomato farmers,” he says. “The price has gone down. People will be able to make a good living doing it still—obviously there are very successful tomato farmers—but the high prices associated with the black market are mostly long gone.” The way he sees it, cannabis markets are simply maturing, the way all markets do. “With mature markets, you see people trusting brands,” he says. “In these unstable markets it’s all about the latest and greatest. I look at it like a Top 40 playlist and there’s not a lot of things that stand the test of time… I think in the future brand trust is going to be a much bigger thing, instead of the latest and greatest thing.” For Loud, that future is about using meristem tissue culture to secure clean, pathogen-free genetics and following his nose to the next facet of cannabis waiting to be expressed through purposeful breeding. And when it comes to all the new players in the weed game, the ones who never experienced the wild rush of the bad old days of total prohibition? Loud feels like anyone who would subject themselves to the very different challenges of the legal weed game—drug war veteran or not—is a warrior in their own right. He says his most recent visit to MJBizCon convinced him that the remaining players are all driven by passion, which he believes is the key ingredient to success. “They aren’t window shopping, they’re really invested in this industry,” he says. “There’s hardship, but the people sticking it out are really passionate about the plant and this is what they’d be doing even if they weren’t getting paid and that’s me, I’m that guy. I’m gonna be breeding no matter what, I’m gonna be smoking no matter what, because this is what I was meant to do.” This article was originally published in the May 2024 issue of High Times Magazine.

https://hightimes.com/

Sunset Connect Buys the Ticket, Takes the Ride

With a tagline featuring a founding year “Since before we could tell,” Sunset Connect alludes to the fluctuating legal status of the world’s most favored flower. When I visit the manufacturing space in San Francisco—a former lambskin condom factory and, later, a photography studio—the bright white walls are a welcome break from the dark gray day outside. It’s the last day of January 2024, and we’re in the middle of an atmospheric river called a “Pineapple Express,” but from founder Ali Jamalian’s upstairs office that oversees the space, I can only hear taps of the rain outside. Jamalian’s broad smile and kind eyes are the type that light up a room. Coupled with that, he’s a great storyteller. Through personal trials and triumphs, Jamalian has grown into a voice that remembers the outlaws of pot’s past. And, with his brand Sunset Connect, he’s proudly repping the profound legacy that San Francisco represents in shaping the availability of cannabis around the world. “You have to be an activist,” Jamalian says of operating a cannabis company in the City by the Bay. “You have to advocate for the industry.” Locals will first notice that Sunset Connect’s logo and branding borrow inspiration from Muni, San Francisco’s public transportation system, including buses, trains, and cable cars. The script on “Sunset”is in the same curving worm-like font as the iconic 1975 Muni logo. And, with packaging showcasing the design of paper Muni bus transfer tickets that were retired in 2016, its brand identity stands as a sort of insider call back to an earlier time. Sunset Connect has evolved over the years but is now putting out hash-infused dogwalkers and trim pre-rolls. The pre-rolls retail at $5. “I think what we really pride ourselves in is the separation, getting all the fan leaves and the sticks and stems out and really being left with sugar leaf and small buds,” Jamalian says as we walk the manufacturing floor. “My whole point was like, ‘Dude, you’ve got to be able to get something to people at a fair price that they can afford every day.’” Jamalian believes the batch size, 100 grams, is critical to the salability of his 1-gram pre-rolls and says he’s selling about 25,000 each week.  “We firmly believe that the success of our joints is that they’re hand-topped and twisted,” Jamalian says as I watch an employee complete packing the herb down and adding the wick-like twist of paper at the top. “I think that’s what gives you the good draw and the fact that we grind it in tiny batches of 100 grams.” Steered by hippies and activists who sold grass in the 1970s and provided cannabis to those in medical need in the 1990s, San Francisco stands as a significant touchpoint for the medical marijuana movement. Actions that took place there and in the greater San Francisco Bay Area led California to become the first state to approve medical marijuana in 1996. The Sunset Connect brand was born in California’s medical marijuana era and was granted a state license as a manufacturing and distribution company in the adult-use cannabis marketplace in 2020. Based in the city’s Sunset District and known as The Sunset Connect, Jamalian and his best friends since freshman year at the University of San Francisco brought cuts of classic strains to medical marijuana dispensaries circa 2014. This included White Widow—an extremely popular strain in the late ’90s and early 2000s following its win at the 1995 Cannabis Cup—and a strain breeders Mr. Sherbinski and Jigga created in a Sunset District garage around 2010, Sunset Sherbert. While the Sunset Connect team went official in 2014, they had been growing pot together for some time before that. Back in 1999, the feds charged Jamalian with possession and intent to distribute weed, and since he was a German-Iranian with a green card, he faced deportation. Spooked from the ordeal, he returned to Germany for a time and returned to the United States when his friends called him back into the game. “At that point, the boys were already blowing up like 15 houses in the Sunset and around town and doing really well with it, vending to dispensaries, but mostly moving it black market,” Jamalian says. “So I came back… I started with one house on 47th [avenue] and about two to three years later about four to five houses and then between us we had like 30-35 homes.” In 2018, when Jamalian started working to bring Sunset Connect into the adult-use cannabis marketplace, he began to get politically involved with organizations designed to advocate for the industry. But within those groups, such as the now-defunct California Growers Association, he says he often found business owners campaigning on behalf of their companies rather than the community. “Everyone that I worked with was moving weight and risking their lives to move weight,” Jamalian says. “And most of them didn’t get to transition…The heads in the Sunset weren’t being considered because we didn’t have warehouses; we had homes. Because back then, the criminal liability of growing at home was a lot less than the criminal liability of a 90-light warehouse.” His role as a public-facing cannabis grower took the next step when Jamalian connected with Jane Kim, a member of the San Francisco Board of Supervisors, who was running against acting mayor London Breed in 2018. “When I met Jane, I told her I was already trying to build this place up and go legal, and she’s like, ‘In this city, you have to become an activist,’” Jamalian says. “She really taught me the way around City Hall.” In January 2020, Jamalian became a member of the San Francisco Cannabis Oversight Committee, a representative group of cannabis company leaders that advise the board of supervisors and the mayor regarding implementing and enforcing city laws and regulations relating to cannabis. Beyond his political work, he’s always looking to network inside the cannabis community and puts on a monthly gathering in a Sunset District bar for budtenders. “I think building a community, not to sell your product, it gives people an emotional connection to your brand,” Jamalian says. “We were the underdog, and we still are, and I think people like to root for the underdog.” Kim’s cousin, Sam Joo, now works for Jamalian, handling compliance and production. Upon meeting him, Joo is locked in deep on the computer, navigating a change in California policy that vastly reduced the number of labs authorized by the state to test cannabis. When we chat about the current scene, he uses a phrase that became a touchpoint in describing California cannabis before its adult-use stage, the Wild West. “We don’t have a choice but to build our production around what the labs are capable of doing,” Joo says. “I guess the excuse is that it’s new. I don’t know if other industries have faced what the cannabis industry is facing, but it feels like the Wild West, you know, where nobody really knows what they’re doing.” The fluctuating nature of the regulations in the state’s adult-use cannabis industry has compounded with other factors, such as a dip in wholesale prices, in driving many longtime weed companies out of the market. Cannabis cultivators in California are disappearing in droves, and San Francisco is no exception to those statistics. Reporting done by the Cannabis Business Times in March 2023 shows that the state has lost thousands of cultivation licenses in recent years. Jamalian tells me he’s learned that surviving in the cannabis industry means you have to be willing to expand and contract. He is readying for his brand to grow and plans to cultivate and release flowers under the Sunset Connect brand again soon. With that anticipated launch, he’s bringing back Dosi-Pie, a Velvet Pie and Do-Si-Dos cross. It’s the strain he says the brand was most well-known for at dispensaries back in the day. Sunset Connect’s current version has a peppery spice on the nose and tastes how sandalwood incense smells. Now in his second term on the oversight committee, Jamalian uses his decades of experience in the city’s cannabis scene to advocate for the weed industry that remains in San Francisco. “The market is on a downward slope; there’s going to be 30% of brands who disappear,” he says. “People are looking for good flowers from San Francisco. Also, there’s not a lot of outfits here anymore producing really good flowers. “So, while San Francisco contracted, I think similar to the AI boom, cannabis companies are about to bloom again. Because the few that are left, they have a foot in the market, they’re now established, and people are like, ‘Wait, San Francisco is where the best weed in the world all comes from.’” This article was originally published in the May 2024 issue of High Times Magazine.

https://hightimes.com/

NOT TRAPPED: the Hesh take.

When you’re a minority and you say you work in cannabis, or with cannabis, everyone automatically thinks you’re trapping. Growing up I saw my dad go back and forth to prison for years. I never asked why or what he did; I just knew he went, and I was glad when he came home.  In May of 2007, when I was in 5th grade, he got out. He came to pick me up (from school?) in a red 2005 Chevy Cavalier that was filled with smoke. My 2 brothers were in the backseat. I would usually only see them during holidays, or visiting my grandma in prison. She was not there for weed. By then any stigma was gone, I was immune to it. I knew what it was forever because my mom and other family members frequently smoked it, but I had never seen an adult smoke like, right next to me, in plain sight—and while driving, at that. I remember asking him, “You can just smoke anywhere and everywhere?” He proceeded to pull out a laminated paper card and explain to my 11 year old self how he’s prescribed it, and that I needed to “stay in a fuckin’ kids place.” That was that. Needless to say I proceeded to watch him roll countless swishers, all while driving with his kneecap, on our way up to Hanford, California. The whole time we’re listening to his old cellmate Messy Marv on repeat. I knew this drive like the back of my hand from all those prison trips for my grandma, so I sat back and turned on my PSP to watch Lords of Dogtown while loads of PomPom smoke was being blown from my dad’s mouth, through the steering wheel, bouncing off the blowing AC vent, right into my face. By this point I was already familiar with smoking. I had tried it a couple of times at the skatepark with some older friends, so it’s not like he was giving me my first contact high or anything, but it was just around like that. Hours later, we finally pulled into the town home projects around 4 pm. My cousins and aunties immediately surrounded the four of us, greeting us all with hugs and handshakes. In the distance you could see my uncle Jamel run out of the house. Standing at about 6’3 and weighing probably 380 lbs, Jamel walks over to my dad, stinking of cheetos, ass, and stress weed. Completely out of breath he yells “PJ, I KNOW YOU BROUGHT THAT MEDICAL BOMB WITH YOU!” My dad quickly replied “Man this strawberry cough gon’ have you sleep in the toilet again, stop!”  Quick side piece: Apparently on a prior visit to Hanford the cops raided my auntie’s apartment. In their search of the spot they found Jamel asleep upstairs on the toilet, while my dad was in the garage with a woman half dressed explaining his medical condition to the police on the scene. He even showed them his legal medicinal cannabis license. You see, in 2007 it wasn’t as common for people to have a medicinal recommendation for cannabis as it is today. My auntie Danetta yelled out in the background “PJ, I’M GOING TO JAIL FOR WEED!!!!!” as my dad explained why the house constantly smelled like it to the head lead. Shortly after that the whole house was let out of their zip ties and handcuffs. Well, beside Jamel, who had a minor warrant out for his arrest.  Now back to my story. When we arrived this time I watched my dad pull out a duffle bag from the trunk of the car we drove up in and head into the garage, which was his normal post. Soon after, other cars filled up the alley, and I watched people leave happily after a brief meeting with my dad. Some had frowns on their faces, sometimes making different remarks about the price. But after seeing how stressed my dad was dealing with all this, I thought to myself: “I never wanna deal with this shit.”  Fast forward 17 years later, and now I find myself in certain places, like weed events, genuinely there just to have fun, and I get random people asking for my number, or direct messages from kids on social media asking for my telegram.  I do my best to laugh so they don’t see I’m either mad or confused. I tell them I just smoke it. Sometimes I do product development for my homies. I’m not in sales. On top of my short patience, I don’t really have customer service skills, and I already smoke a quarter pound myself in about 2-3 days, on average. I salute to all my pack shifters, ounce movers, and the craziest of the clientele server, the shake shaker. Honestly, if you have the patience (and time) to be a budtender, I salute you too, because that shit seems like it’s a hassle in itself!  I just think it’s funny being young and black in the weed game, because people be so surprised that I don’t care about what the rappers or celebrities are smoking. I’m far more interested in what Sourwavez, TrulyRedPanda, or LA Flav are dropping—or what Jon C is talking about.  I guess the point is, you look silly when I walk into a room and you think I want to “steal your custies.” In reality, I’m a “custie” myself. That worried look from dealers is always funny—or the snobby looks from growers who think I don’t know anything. That’s stereotypical shit, most of the time. But that look they get when my actual snobby weed friends come over and they see what time it is NEVER gets old.

https://hightimes.com/

Best THC Gummies: The Ultimate Guide to Euphoric Edibles

These THC-infused candies deliver a precise dosage per gummy, suitable for both experienced users and newcomers. Available in various options, including 25 mg Delta 9 THC gummies or those with a balanced THC and CBD mix, they cater to a spectrum of experiences. You can easily navigate the complexities of THC and CBD, ensuring an experience that caters to both recreational desires and therapeutic needs. Remember, the onset time can be around 30 minutes, so patience is key. Keep your gummies away from direct sunlight, and always review lab test results to ensure safety and potency. This comprehensive guide provides a list and review of the best THC gummies of 2024. You can select the most suitable gummy product from our list for effectiveness. Mystic Labs has a 9.8/10 rating for its exceptional THC gummies, with high customer satisfaction rates reflecting their commitment to quality, potency and service. Its top-selling gummies are praised for their great taste and consistent effects, underpinned by reliable shipping and return policies. The brand’s gummies are made with a full-spectrum formula, ensuring users benefit from the entourage effect of cannabinoids. They can indulge in a variety of flavors like Blood Orange, Goji Berry, and Savage Lime, each designed to enhance your THC experience. Esteemed platforms like High Times and Leafly vouch for their quality. The key features of the gummies include accurate THC dosage and suitability for new and seasoned users. Customer reviews on the official product page praise the gummies’ effectiveness and flavor. One said, “These do the trick for me. Relaxing and mellow.” General Disclaimer: Educating yourself about THC and its potential risks before using it is crucial. Follow the link here to find more information on this topic. Erth Wellness’s 9.7/10 rating reflects its dedication to customer satisfaction. It aims to provide safe, potent CBD and THC products. It’s quickly become a preferred source for premium gummies. Erth Wellness uses a broad-spectrum formula in the gummies, offering a rich cannabinoid experience without the psychoactive effects of THC, perfect for those seeking a non-intoxicating option. Its flavors, which include Pineapple Express and Strawberry Cough, and effectiveness have been reviewed positively on Weedmaps and CannaInsider. The product’s key features include adding natural ingredients, delicious fruity flavors, and a wide range of gummy options. Customer satisfaction is evident: “These gummies are game-changers,” said one user. Established in 2016, FabCBD offers potent, safe THC products. With a solid 9.5 out of 10, this brand excels in customer satisfaction thanks to its efficient shipping, hassle-free returns, and competitive prices. It collaborates with reputable hemp farms to guarantee quality, supported by customer-centric policies. The gummies boast a full-spectrum formula, providing a complete cannabinoid profile for enhanced effects. The formula is carefully made to ensure a high-quality, potent product. The gummies also come in two flavors: Guava and Melon. High Times and Leafly reviews confirm the brand’s commitment to excellence. Some of the key features of the gummies include the non-inclusion of GMO ingredients, third-party lab tests, constant THC dosage, and smooth effects. On the official product page, one customer said, “These gummies are a game-changer for relaxation!” Binoid exceeds expectations with an excellent 9.4/10 rating, thanks to exceptional THC gummies, customer service, and user-friendly policies. The brand specializes in high-quality THC products and has become a favorite among experienced users for its potent and flavorful offerings. Binoid offers full-spectrum CBD products, ensuring users experience the entourage effect. The formulations provide maximum efficacy and purity. The brand’s THC gummies come in various flavors to please every taste bud, but the Super 7 gummies are available in a Grape Cotton Candy flavor. The key features of the gummies include diverse flavor options, clean and safe production methods, and full-spectrum THC in all the gummies. HighTimes and Leafly have recognized Binoid for its excellence in the THC market. One customer review on the official Binoid product page states, “The effects are just what I was looking for!” Edobles earns a good 9.2/10 rating with its diverse product range, superior customer service, and competitive pricing. It offers a potent, flavorful range of gummies blending Delta 9, Delta 8, and HHC. The flavors include Mixed Berries and Sour Lemon. The THC gummies use only a full-spectrum formula, incorporating a range of cannabinoids to enhance the overall effect through the entourage effect. Some of the key features of the gummies include the non-inclusion of artificial ingredients, unique and natural flavors, and a consistent THC dosage. It is well-reviewed on High Times and Cannabis Culture for its effectiveness and taste. One customer raved on the official website, “The strawberry delta gummies not only taste great but also provide the perfect level of chill.” We evaluated each brand’s reputation, formula, and flavors to create this list of the best THC gummies. We also checked brands that have changed the game in THC gummies, considering customer reviews and comments across various platforms. The reputation of any brand or company can make or mar its relationship with existing and potential customers. Therefore, we carefully checked and picked only those with excellent reports. The formula for these gummies often includes citric acid, which adds a zesty tang and acts as a preservative. High-quality THC gummies also feature a balanced cannabinoid profile, essential oils, and natural flavorings to enhance the overall effect. THC gummies come in various mouthwatering flavors, ranging from tropical fruits to classic sweets. These flavors mask the natural earthiness of cannabis, making consumption a pleasurable experience. Users praise the consistent dosing that allows for a controlled experience, the quality of the high, and the delicious flavors. Negative comments tend to focus on taste preferences or dissatisfaction with the strength of effects, underscoring the subjective nature of cannabis edibles. THC gummies are a popular, inhalation-free option for experiencing THC’s benefits, suitable for various lifestyles and preferences. Users can better manage their intake and target specific ailments. The convenience and discretion of gummies make them suitable for various lifestyles and preferences. Whether you’re looking for relief, relaxation, or just a bit of euphoria, THC gummies could be a delightful addition to your wellness routine, provided they are used responsibly and by legal regulations. Related Topics: Best Delta 9 Gummies in 2024: Unveiling the World of THC Edibles Best Delta 8: The Ultimate Guide to Top Quality Products in 2024 Selecting the Best HHC Flower for the Essence and Benefits

https://hightimes.com/

Department of Justice Publishes Proposed Rule in Federal Register To Reclassify Cannabis

The federal government is finalizing the reclassification of cannabis. The U.S. Department of Justice published a proposed rule in the U.S. Federal Register to reclassify cannabis from Schedule I of the federal Controlled Substances Act (CSA) and move it to Schedule III. For over 50 years, cannabis has been classified as a Schedule I controlled substance, a classification reserved for drugs with “no medical value.” Many critics from the cannabis industry have criticized the reclassification, saying that only decriminalization is enough and that moving cannabis to Schedule III only puts it in a slightly less restrictive category. Then on Oct. 6, 2022, President Biden asked the Attorney General and the Secretary of Health and Human Services (HHS) to launch a review of how cannabis is classified. After receiving HHS’s recommendations last August, the Attorney General first sought legal advice from the Justice Department’s Office of Legal Counsel (OLC). Then, based on the HHS’ medical and scientific determinations, and OLC’s legal advice, the Attorney General exercised his authority under the law to initiate the rulemaking process to reclassify cannabis. The proposed rule was first announced by the DOJ Office of Public Affairs on May 16, and follows a series of recommendations and approvals. “The Department of Justice proposes to transfer marijuana from schedule I of the Controlled Substances Act (CSA) to schedule III of the CSA, consistent with the view of the Department of Health and Human Services (HHS) that marijuana has a currently accepted medical use as well as HHS’s views about marijuana’s abuse potential and level of physical or psychological dependence,” the proposal for the federal register reads. “The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing.” “If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations,” the proposal reads. “If marijuana is transferred into schedule III, the manufacture, distribution, dispensing, and possession of marijuana would remain subject to the applicable criminal prohibitions of the CSA. Any drugs containing a substance within the CSA’s definition of “marijuana” would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act (FDCA). DOJ is soliciting comments on this proposal.” The National Organization for the Reform of Marijuana Laws (NORML) offered cautious enthusiasm for change, finally at the federal level. “NORML is in a unique position to mobilize interested parties to provide their perspectives throughout the public comment period and we will be encouraging advocates and experts to do so in the coming weeks,” said NORML’s Deputy Director Paul Armentano. “In particular, it is important that the voices of both physicians and patients are heard and considered, as the Justice Department weighed the real-world experiences of doctors and their patients in medical cannabis states when making their recommendation to reclassify.” “Additionally, NORML will be submitting our own comprehensive comments substantiating the evidentiary record that cannabis possesses accepted medical utility and comparatively low dependence liability,” Armentano continued. “We will also be addressing a number of the issues raised by political opponents with respect to cannabis’ impact on public health, making it clear that these concerns do not warrant the continued classification of cannabis as a Schedule I substance. While NORML ultimately favors descheduling rather than rescheduling, we understand that reclassification is associated with both symbolic and tangible benefits to the cannabis community, both in the short-term and the long-term.” Now that the rule proposal has been published on the Federal Register, the public comment period will kick off and run for about 60 days.​​ The rescheduling of a controlled substance must undergo a formal rulemaking procedure that requires a notice to the public, informing them of an opportunity to comment and an administrative hearing. Then the DEA will gather and consider information and views submitted by the public, in order to make a determination. During that process, and until a final rule is published, marijuana remains a schedule I controlled substance. Comments must be submitted electronically or postmarked on or before July 22, 2024. Interested persons may file a request for a hearing or waiver of an opportunity for a hearing or to participate in a hearing pursuant to 21 CFR 1308.44 and in accordance with 21 CFR 1316.47 or 1316.49, as applicable, which must be received or postmarked on or before June 20, 2024. The DOJ encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Individuals can go to the regulations website and follow the online instructions at that site for submitting comments.

https://hightimes.com/

Leaked Photos Show Banksy at Work

Photos over 20 years old show the enigmatic artist known as Banksy at work, painting a 17-ton train car in Malaga, Spain that is now worth nearly $2 million dollars. Little did the artist know that a man who was talking to him took a photo and held on to it all these years. Gloucester Live reports that the never-before-seen photos of Banksy that emerged show the artist painting his biggest ever artwork. The train car was called The Turbozone Truck, it went up for auction with the starting price of £1 million ($1.27 million USD)  to £1.5m ($1.9 million USD) after it was authenticated by his studio. The photos also appear to be authentic as it is a well-known piece by the artist. “I used to spend a lot of time in Bristol,” the unidentified photographer said. “Our friends told us about this party that was going on in Spain and we thought why not? At the time we were very aware of Banksy’s stuff when it was popping up, but he was still quite under the radar.” The pictures were taken in the early hours of a New Year’s Day party in Malaga. At the time, they had no idea how big Banksy would eventually become after he blew up. “Then we were at the party and saw this guy painting—the three of us just turned to each other and said it’s got to be Banksy!” he said. “Little did we know at the time he would go on to become one of the most famous artists in the world.” The photographer then says he approached the man and asked him if he was the elusive street artist, and says the man confirmed he was Banksy.  “It wasn’t much of a conversation–-I remember we said how we’d seen some of his work in Bristol, as far as I remember, he had been flown over from Bristol.” The train car featuring Banksy’s artwork spent years traveling from Europe to South America as part of a tour for Turbozone’s Cinderella show. It is also featured in Banksy’s official book, Wall and Piece, which was published in 2006 and authenticated by the artist via his studio, Pest Control. The identity of Banksy has never been revealed officially, however a number of names have been linked with Banksy in the past: Robert Del Naja, Robin Gunningham, Art Attack’s Neil Buchanan. Gunningham is probably among the best theories for Banksy’s identity, BBC reports. Banksy’s former agent Steve Lazarides claimed to show the artist at work in a separate photo, although none of the images new or old show his face.  The enigma known only as Banksy re-entered the world of cannabis with a new permanent installation in a Toronto, Ontario-based dispensary in 2020. The unofficial king of guerrilla art—in the form of graffiti—left a breadcrumb trail of mystery throughout Europe and across the world through stark political messages and epigrams. But now, the vandal’s art can be appreciated by cannabis consumers who often share his political beliefs. Tokyo Smoke brand announced its new cannabis retail store in Toronto, Ontario—as well as its permanent installation of an exclusive Banksy collection of art. The collection will feature “never-before-seen” works from the artist, as well as other notable pieces from other artists. The store was armed with plexiglass dividers at the retail counter and reminders to observe social distancing. Tokyo Smoke, which is a subsidiary of Canopy Growth Corp., opened the new location on 21 Bloor St. E. and the property is wheelchair accessible.  The artist appears to favor hash resin, a common item found in the U.K. and Europe. In 2003, for instance, the artist illegally hung his own art at the esteemed Tate Britain—formerly called the National Gallery of British Art—in an act he said was inspired by cannabis resin. His self-hung piece was entitled, “Crimewatch UK Has Ruined the Countryside For All of Us,” and was placed next to a 19th century landscape. Like all of his public pieces, it carried a political message buried in dark humor. Each time a Banksy piece is spotted, the media loses their minds. Banksy’s famous piece “Rage Flower Thrower” depicted a Black Bloc-looking protester throwing a bouquet of flowers instead of a Molotov cocktail. The Rage Flower Thrower, however, has been marketed as “Weed Thrower” on T-shirts and other merchandise on Ebay. The artist is best known for “Girl With Balloon,” a stenciled graffiti painting in East London. In 2018, a “Girl With Balloon” print was auctioned off in London at Sotheby’s for £1.042 million—only to self-destruct moments later. It was one of the latest of Banksy’s antics that once again shocked the world.

https://hightimes.com/

New Assembly Bill in New York Seeks To Legalize Psilocybin Service Centers

New York legislation Assembly Bill 10375 was recently introduced by Assembly Health Committee Chair Amy Paulin and aims to legalize psilocybin service centers. If passed, the A10375 would amend public law “in relation to promoting the health and well-being of the citizens of the state of New York by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi,” the bill stated. It would also require that the Department of Health (DoH) take charge of regulations, which involves cultivator licenses and approving psilocybin service center facilities. It would also create a “Regulated Psilocybin Advisory Board” made up of 13 members to study federal laws and policies regarding psilocybin, and offer advice and recommendations to the DoH. The purposes of the board would be to “develop a long-term strategic plan for ensuring that psilocybin services in the state will become and remain a safe, accessible and affordable therapeutic option, including in therapeutic and medical treatments, for all persons eighteen years of age and older for whom psilocybin services may be appropriate.” Psilocybin business expenses would be tax deductible, and proceeds and fees would go back into the program to fund “administration and other costs relating to programs pursuant to this title, including but not limited to public education and risks of using psilocybin.” Currently there are 58 conditions that would qualify for a patient to utilize the services of a psilocybin center, which ranges from glaucoma, HIV/AIDS, migraines, multiple sclerosis, post-traumatic stress disorder, sleep disorders, treatment resistant depression, and so much more. Additionally, patients with other conditions not included in the initial list can also be considered for psilocybin therapy if it “has been identified in a study published in a medical or scientific journal.” In order for a patient to receive a permit for psilocybin therapy, they must first receive a health screening and complete a permit course. The bill wouldn’t legalize psilocybin, and consumption, cultivation, and sales would be prohibited. Violators would be hit with a $250 fine and a maximum of 15 days imprisonment. As of May 21, the bill has been sent to the Assembly Health Committee, of which Paulin is the chair. Other legislation involving psilocybin has led to promising progress. In February 2023, Assemblymember Pat Burke introduced Assembly Bill 03581, which would establish a psilocybin assisted therapy grant program and allow patients to engage in such treatments either in a licensed treatment center, or at home if the patient cannot travel. “This country is facing a mental health crisis,” Burke wrote on X last year. “I am looking at all options to alleviate the pain so many are feeling. Breakthrough medicines like psilocybin are showing tremendous benefit. I carry the bill to legalize psilocybin therapy. Let’s get it done!” In February 2024, Burke introduced Assembly Bill 08349 which would create a psilocybin  therapy pilot program for 10,000 veterans and first responders. “We’re in a mental health crisis, and so we need every tool that’s available to us,” Burke said. Meanwhile, the state’s legal cannabis industry continues to develop. In mid-April, the New York Cannabis Control Board approved 101 adult-use cannabis licenses. “With the Cannabis Control Board’s issuance of 101 adult-use cannabis licenses, New York’s legal cannabis industry continues to make significant progress with over 400 licenses issued in 2024,” Gov. Kathy Hochul said. “Strengthening New York’s equitable cannabis industry and ensuring the hard-working small business owners operating in the legal market have the licenses to open are the best way to protect the integrity of sales in New York.” As of late April, the state celebrated the opening of its 100th dispensary, called Big Gas, which opened through the help of the New York State Cannabis Investment Fund. “New York State continues to make progress on standing up a safe and legal cannabis industry for business owners, farmers and residents across the state,” said Hochul about the news. “Today marks a historic milestone in establishing a thriving and equitable industry in our state with the 100th brick-and-mortar store opening.” The topic of psilocybin continues to influence more illuminating research studies.  One such study which was published this month in the Journal of Psychoactive Drugs showed evidence that it won’t change a person’s belief as an atheist, agnostic, or believer in God. “These findings suggest that concerns that psychedelics could change metaphysical beliefs or result in ‘conversions’ across religious affiliations may be overestimated,” wrote researchers of their findings. They added that “concerns related to changes in non-naturalistic beliefs or religious affiliation may be exaggerated.” Other recent studies include a dive into psilocybin as a meditation enhancement, show evidence that psilocybin isn’t associated with paranoia risk, and proves that natural psilocybin has more therapeutic benefits in comparison to synthesized psilocybin. Another psilocybin treatment center recently opened up in Oregon, called Ashland Healing Center, which is also the first black-owned treatment center. Additionally, the Oregon Health Authority approved another psilocybin license to Kaya Holdings Inc., for a business called The Sacred Mushroom, which plans to open sometime in June.

https://hightimes.com/

Monitoring Weed’s Business Landscape

The Massachusetts Cannabis Control Commission (CCC) recently shared that the state collected $1.8 billion in cannabis sales during 2023. The figure reflects a combined total of recreational cannabis sales ($1.56 billion) and medical cannabis sales ($225 million). That’s a significant increase between total sales from 2022, which landed at a total of $1.49 billion ($1.42 billion for adult-use sales and $260.2 million for medical cannabis sales). “This continued growth confirms that Massachusetts’ regulated marijuana industry is still a maturing market,” CCC acting chair Ava Concepcion said in a press release. “As more retailers and delivery licensees come online, flower prices start to stabilize, and the stigma surrounding cannabis slowly dissipates—legal, tested products are becoming more accessible, affordable, and approachable than ever before, and that’s reflected in the multiple sales records licensees broke in 2023.” Sales from December 2023 showed the highest amount of sales collected for a single month at $140.1 million, surpassing the previously highest month for sales since August 2023. Massachusetts’s adult-use cannabis industry was approved by voters in November 2016, and sales first began in November 2018. Over time, the cost of cannabis flower has greatly decreased, with the CCC recording the price of an average ounce at $14.13 in December 2020 that dropped to $5.66 per ounce as of December 2023. In year-to-date milestone statistics for Massachusetts’s adult-use cannabis industry, which began in December 2018, it collected $1 billion in sales in October 2020, $2 billion in August 2021, $3 billion in April 2022, $4 billion in December 2022, and $5 billion in August 2023.  Ever since Michigan launched adult-use sales in December 2019, the state has become one of the fastest growing cannabis industries. Following the release of December 2023 sales data, the Michigan Cannabis Regulatory Agency (CRA) shared that the state collected a total of $3.06 billion in combined adult-use and medical cannabis sales in 2023, which is major growth compared to sales collected in 2022 ($2.3 billion in combined sales). CRA executive director, Brian Hanna, told WGVU Public Media that the continued success of Michigan’s adult-use cannabis industry is due to a few factors, including cannabis tourism. “We are a state that has an adult use program surrounded by states that don’t,” Hanna told the news outlet. He also added that based on the $3.06 billion from 2023 cannabis sales, that would equate to $305 per capita, or an average amount per person. Sales aren’t the only increase seen in the Michigan cannabis industry, as Hanna told Crain’s Detroit that there has been an increase in job opportunities as well.  “As we head into 2024, the CRA continues to focus on transparency and communication, working with stakeholders as the industry continues to grow,” said Hanna. “We’re committed to supporting Michigan’s cannabis licensees who currently employ over 35,000 employees, a 23% increase from December 2022.” Data published by the Oklahoma Medical Marijuana Authority (OMMA) on Feb. 1 in its monthly licensing report show a continued decrease in overall active cannabis business licenses, as well as patient numbers. While OMMA data from February 2023 shows that the state once had 11,974 active cannabis business licenses in total, that number has decreased to 8,025 licenses as of February 2024. This total includes 4,347 cultivator licenses, 2,293 dispensary licenses, 1,248 processor licenses, 98 transportation licenses, and 26 lab testing licenses. Oklahoma voters made it clear that they don’t want adult-use legalization when they rejected Oklahoma State Question 820 in March 2023, but February 2024 data shows that medical cannabis patient numbers are also dropping as well. In February 2023, Oklahoma had 369,468 active medical cannabis patient cardholders and 1,554 caregivers, and 2024 numbers reflect a decrease to 345,308 licensed patients and 1,304 caregivers. In response to significant oversaturation in the cannabis industry, Oklahoma Gov. Kevin Stitt signed House Bill 3208 in May 2022 to implement a moratorium on cannabis business licenses. The ban was extended in May 2023, and is currently set to last until at least August 2026. However, according to an OMMA-commissioned report called “Cannabis Public Policy Consulting” that was published in June 2023, Oklahoma still had 32 times more cannabis than necessary in order to meet the demand of approximately 355,000 medical cannabis patients (the OMMA’s patient number for that month). Both legal and illegal Canadian cannabis prices are nearly the same, according to a recent data revelation. A company called Deloitte, which offers audit, consulting, tax, and advisory services, alongside publication collaborator Neobi, recently published a report entitled “Clearing the Smoke—Insights into Canada’s Illicit Cannabis Market.” The research report evaluated 624 legal and 57 illegal online stores in Canada between May and June 2023. One of the study’s most notable observations included a flower price comparison from both legal and illegal stores—which stated that the price difference showed that illegal flower was only 20% cheaper. When reviewing varying flower prices between one gram and up to 28 grams, the average price from illegal cannabis was $6.24 per gram, compared to $7.96 per gram for flower in legal stores.  “The gap in prices has considerably narrowed since the last pricing comparison performed by Statistics Canada in Q4-2019, when illicit flower products were priced 55% lower, with the current average price at $5.73 per gram for the legal market—indicating that declining prices in the legal market may have contributed to more capture of the market,” authors of the report explained.  Other findings included how legal stores had fewer stock keeping unit (SKU) counts (538) compared to illegal websites (918). When examining the breakdown between product percentages, legal storefront inventory included 25.6% flower, 25% pre-rolls, 16.1% edibles, 13.1% extracts, 11.1% vapes, 6.6% beverages, 2.2% topicals, 0.3% seeds, and 0.0% for other psychedelics that are currently illegal. Illegal store inventory looks quite different though, with 36.9% of all inventory being flower, followed by 2.6% pre-rolls, 15% edibles, 32.7% extracts, 4.3% vapes, 0.5% beverages, 0.9% topicals, and 7.1% other psychedelics.

https://hightimes.com/

Study: Daily or Near-Daily Cannabis Users Outnumber Alcohol Users of Same Frequency

The rising prominence of regular cannabis use over alcohol use is nothing new.  We’ve witnessed myriad research in recent years showing that states with legal recreational cannabis see decreases in alcohol use, that Gen Z tends to prefer cannabis over alcohol and other reports noting that cannabis has consistently generated more tax revenue than alcohol and cigarettes in states like Colorado and Washington.  So it’s not necessarily a surprise that, for the first time, the number of Americans who use cannabis on a daily, or near-daily, basis has eclipsed those who drink alcohol at the same frequency. Associated Press first reported on the recent analysis of national survey data, finding that an estimated 17.7 million people reported daily or near-daily cannabis use, compared to 14.7 million daily or near-daily American drinkers. For comparison, 1992 was the low point for daily cannabis use as less than 1 million people at the time said they used cannabis every day. According to study author Jonathan Caulkins, who researches cannabis policy at Carnegie Mellon University, alcohol is still more widely used, but 2022 was the first time that the level of cannabis use overtook daily or near-daily drinking. “A good 40% of current cannabis users are using it daily or near daily, a pattern that is more associated with tobacco use than typical alcohol use,” Caulkins said. Caulkins’ study, titled “Changes in self-reported cannabis use in the United States from 1979 to 2022,” is based on data from the National Survey on Drug Use and Health and published in the journal Addiction on Wednesday. It notes that there was a 15-fold increase in the per capita rate of reporting daily or near-daily cannabis use from 1992 to 2022, whereas the 1992 survey found 10 times as many daily or near-daily alcohol users compared to cannabis users. Reflecting alcohol as the more commonly used substance, the study notes that the median drinker reported alcohol use on four to five days in the past month, versus 15 to 16 days of past-month use for cannabis users. Past-month cannabis consumers were almost four times as likely to report daily or near-daily use and 7.4 times more likely to report daily use, according to the study. Of course, this trend is no accident. It’s the product of gradual policy changes, advocacy and broader education surrounding the true nature of cannabis use and cannabis consumers following decades of skewed propaganda and harsh criminalization. The study notes four major periods of cannabis policy fluctuation in the U.S., starting with liberalization in the ‘70s as 11 states decriminalized or reduced cannabis-related penalties. This is alongside the Shafer Commission report, which countered the popular notion that cannabis users were dangerous, concluding that users tend to be more passive and cannabis does not cause widespread danger to society. It also recommended social measures to curb usage rather than criminalization. The more conservative policies of the 1980s and early ‘90s followed, with President Reagan and Bush Sr.’s now somewhat infamous War on Drugs in full force. The third major period outlined by the study spans 1993 to 2008, a period of “state-led liberalization” underscored by an increasing recognition of medical cannabis contrary to federal policy. Finally, we witness the period of “explicit non-interference by the federal government” starting in 2009, with Deputy Attorney General David Ogden’s memo prompting American attorneys not to focus “federal resources in your states on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.” Just a few years later, Colorado and Washington became the first states to legalize adult-use cannabis. “There were myriad other changes at the local, state and federal level in both law and policy,” the study notes. “Change has been continual, so these epochs are just signposts, not the only moments of change.” For those who have tried cannabis and who use it routinely, this information may not come as much of a surprise. American attitudes around cannabis have shifted, with the majority routinely sharing they consider cannabis as a safer alternative that alcohol and cigarettes. Research is also increasingly finding a lack of “hangover” effects in cannabis users, showing no evidence of next-day effects following THC consumption. This, of course, acts in stark contrast to alcohol use, so those who use cannabis frequently arguably have fewer obstacles to navigate surrounding general day-to-day functions. In addition, research is increasingly finding that even chronic pot use has minimal effects on motivation. Regular cannabis use isn’t without its faults. The Associated Press report includes the perspective of University of Maryland School of Medicine psychiatry professor Dr. David A. Gorelick, who notes that high-frequency cannabis users are more likely to become addicted to cannabis. Gorelick was not involved in the original study. Some studies have also pointed to increased risk in heart problems among heavy cannabis users (though other studies have suggested the opposite).  There’s also been a recent influx in studies suggesting that cannabis use, especially surrounding high-potency products, produces greater risk in developing psychosis. While substance abuse disorders indeed carry psychiatric comorbidities, there is limited evidence surrounding how this relationship translates to the general population and how much substance use disorders are driven by such comorbidities.  A number of studies have combated that narrative with advocates often arguing that touting this relationship between cannabis use and psychosis is simply the newest iteration of “reefer madness” of past years. Of course, more research is needed to fully determine the health impacts of regular cannabis use — something that the upcoming Schedule III status of cannabis will likely aid in.  That said, regular alcohol use is known to affect how the brain works over time, damage the heart, increase risk of stroke and high blood pressure and weaken the immune system, leaving people more susceptible to illness. There’s also the toll it takes on the liver and pancreas and its potential to cause several types of cancer. While cannabis may not be perfect, even your standard “recreational” user is likely to cite a number of medical-specific benefits they enjoy from their use. Many regular cannabis users utilize it as a means to better wellness or to usher in specific symptom relief while also helping to provide a sense of ease and escape from their struggles.  All to say, research like this often affirms what those in the cannabis community have been saying for years. Perhaps society is finally beginning to catch up.

https://hightimes.com/

Brand Spotlight: Abstrax

When Abstrax started its recent research project, I doubt anyone could have imagined it would discover a whole new universe beneath our still-evolving knowledge of cannabis compounds. Now, they’ve released research suggesting how we understand how weed tastes or smells might just be the tip of the iceberg. Working with 710 Labs, SepSolve Analytical, and Markes International, the research team opened a portal into a world of rare and unseen flavor and aroma compounds in cannabis. Founded in California in 2017, the Abstrax team calls themselves pioneers in botanical flavor technology. Its main business is to provide terpene-driven flavor solutions for industries such as cannabis, beverage, and fragrance. By studying the complete chemical makeup of a cultivar, Abstrax goes through a rigorous process to map out, select, analyze, refine, formulate, optimize, test, reformulate, test, and package before offering companies the truest strain-specific flavors they can produce. It does so through its three divisions: tech, which researches and creates terpene blends for various markets; labs, which conducts botanical testing and offers extraction/analytical technologies; and hops, providing research, products, and services to the brewing sector. Using two-dimensional gas chromatography, a sophisticated separation technique that offers higher resolution than traditional chemical analysis, Abstrax was able to detect pockets of “hidden compounds,” which they believe have a significant impact on odor and can shape the course of how we classify or even shop for weed. Abstrax researchers published the results of their findings in a white paper posted on their website and in the peer-reviewed journal ACS Omega. The research points out that one of the main driving factors regarding how consumers choose cannabis has to do with THC percentages. The battle over whether something is better because it’s stronger has caused more than a few amazing strains to become lost to time. However, another key factor in what someone purchases is and has always been how something smells. Despite restrictions across many states on cracking open a jar and letting someone take a whiff, this obsession with smell has led to terpenes, or terps, becoming the second most important factor that the study identifies when consumers decide which cannabis to buy. Now, packaging lists the most dominant terpenes on the label and uses them as a guide to tell consumers what they can expect. Abstrax and the research team see this as a partial response to the modern pushback to the classic indica, sativa, and hybrid classification system we’ve leaned on up to this point. As the cannabis industry develops more modern ways of labeling and portraying the different varieties of cannabis, it’s looking for new terms to replace indica and sativa, and smell has emerged as a dowsing rod as competitions divide strains between candy, citrus, and gas. Much of the marketing focus on educating base-level consumers past sativa and indica has shifted toward trying to describe to shoppers what these aromatic compounds mean concerning the taste, smell, and psychoactive effects of a strain. It makes sense since, as the research points out, they appear in high amounts, making them a seemingly perfect identifier for classification. Contrastingly, the research asserts that we might be trading one generalization for another in our use of terpenes, pointing to an additional study—“The phytochemical diversity of commercial cannabis in the United States,” published in PLOS One in May 2022—which concluded that in the United States, all cannabis falls into one of three terpene-dominant categories: terpinolene/ß-myrcene, D-(+)-limonene/ß-caryophyllene, or ß-myrcene/pinene. The authors point out that through this system, strains with very different smells ended up in the same groups together. With its skunky, woody aroma, Dogwalker OG wound up next to Tropicana Cookies and Purple Punch, two cultivars with very contrasting smells. Meaning that you can’t always assume something will smell a certain way due to high percentages of certain terpenes. “Taken together, these results strongly suggest that while aroma is a key property in differentiating cannabis varieties and user preferences, the importance of terpenes appears to be overstated,” researchers wrote. The team concluded that terpenes had less of a correlation with the sought-after attributes of a lot of “exotic” cannabis strains and that it must be these alternate classes of compounds at work. The study identified a wide variety of aroma classes, each with diverse functionality, that are responsible for some of the most desirable aromatic qualities found in modern cannabis. Two such classes include tropical volatile sulfur compounds (VSCs), which are responsible for the citrus notes in Tropicana Cookies or Tangie, and heterocyclic compounds like indole and skatole, which produce the rich, intense scent in strains like GMO. They also identified a class of chemicals called flavorants that includes alcohols, ketones, and esters, that go beyond terpenes in affecting the smells and tastes of cannabis. Though found in small amounts, they believe these compounds play a major role by combining to create many of the diverse tastes in modern “exotic” strains like Apple Fritter or Zkittlez. “The discovery of these compounds will play a crucial role in validating cannabis’s authenticity and accurately classifying cannabis varieties in the future,” says Max Koby, CEO and co-founder of Abstrax. Koby also said that utilizing these previously undiscovered cannabis compounds would allow Abstrax to create “the most flavorful and authentic cannabis flavors,” which will elevate the level of the terpene blends and isolate it sells, but also benefit everyone in the space. Consumers can finally have a better toolkit to identify what flavors and feelings they enjoy most. Cultivators, breeders, and brands could someday use this knowledge to better understand which plant components drive these sweet fruit flavors versus the savory ones. “This research helps us better understand flavor in the cannabis experience, allowing us to better educate our customers and select phenos for our genetic library,” says research co-author Brad Melshenker, co-CEO of 710 Labs. One of the more exciting benefits that Abstrax identified for this research was its ability to provide a jumping-off point for researchers and packagers to discover the best way of preserving these specific compounds and provide cannabis with a better shelf life. With additional research planned, Abstrax has announced a partnership to create educational content that helps tell the story of the revelations brought about by its discoveries. Somebody reach out to Paul Rudd. Just like Antman explored and expanded upon the understanding of the microscopic quantum realm the technology employed here shows us there’s so much more happening inside the plant than we’ve ever imagined. Abstrax believes “we stand at the dawn of a new era in cannabis understanding” and that the microcosm of additional compounds inside these plants is part of a secret roadmap researchers are just now learning to draw. This new research will allow us to look for and provide solutions to many of the problems that have arisen from the swift evolution of cannabis from evil weed to essential service. Maybe someday, in a galaxy far, far, away, an android will extend a glass jar to smell the nugs instead of watching an image spin on a budtender’s holopad. This article was originally published in the February 2024 issue of High Times Magazine.

https://hightimes.com/

New Bill Would Remove Louisiana Universities’ Cannabis Cultivation Licenses

Since 2015, Louisiana State University (LSU) and Southern University (SU) are the only two public institutions in Louisiana that can legally cultivate medical cannabis. However, if Senate Bill 228 is signed into law, it would allow private contractors to take their place instead. “They are the only two higher education systems in the country that are in the pot business right now, and it is my belief that it’s time we get them out of that business and let them focus on higher education,” said Sen. Patrick McMath, who is also the sponsor of the bill, told the Louisiana Illuminator. Apparently, LSU and SU received help from two private growers, Good Day Farm and Ilera Holistic Healthcare, to get their own respective farms operational. If the bill becomes law, LSU and SU would transfer their respective cultivator licenses over to Good Day Farm and Ilera Holistic Healthcare, both of which will be permitted to hold on to their licenses for as long as they choose to renew them. As a result, no other cultivators would be allowed to apply for a license. According to Louisiana Illuminator, Good Day Farm in particular has a relationship with legislators who may be attempting to control all cultivation within the state. Good Day Farm’s primary shareholder is Donald “Boysie” Bollinger, one of the richest people in the state, and company president John Davis’ wife, Paula Davis, is a House representative. One of the key people who helped develop legislation for Louisiana’s medical cannabis law, former Rep. Joe Marino, told the news outlet that doing so would create a monopoly on cultivation.  During his time in office, Marino introduced legislation to expand the number of cultivation licenses available for application, although it didn’t pass. In 2022, he also worked to expand the number of cannabis pharmacies, from 10 to 25, which was signed by former Gov. John Bel Edwards. In March, McMath attended a committee hearing for SB-228, and claimed that the Louisiana medical cannabis industry was always meant to be private. He explained that including both LSU and SU was a late-hour floor amendment. “It was never really their intention to be put into this bill,” McMath said. An earlier draft of SB-228 would have still provided a percentage of gross sales from Good Day Farms and Ilera Holistic Healthcare to the universities, but that has since been removed. SB-228 was sent to Gov. Jeff Landry on May 16 for a signature or veto. There has been plenty of other cannabis legislation introduced in the most recent legislative session. The Louisiana legislature initially legalized hemp-based edibles containing delta-9-THC back in 2022, with the knowledge presented by former House Speaker Clay Schexnayder who said it would require a person to consume “tractor-trailer loads” for a person to get high from it. Senate Bill 237 attempts to limit the law, and would make it illegal to sell or manufacture any cannabis products containing THC unless it’s included in a license medical cannabis product. During a committee hearing on May 14, many business owners claimed that such a bill would eliminate the consumable hemp industry that has been built so far, as well as any jobs that have developed from its success. Louisiana Hemp Extractors owner Paige Melancon expressed his frustration about spending the last two years building up his business. “I feel like I’m being fired right now and I want you guys to come with me and fire my employees when we leave here, if you choose to do that,” Melancon said. Supporters of SB-237 such as lobbyist Gene Mills, president Louisiana Family Forum, also spoke about putting an end to consumable hemp products. “Our vision is to build a Louisiana where God is honored, life is respected, families flourish and liberties reign,” Mills said at the hearing. Most recently, SB-237 was heard on the House floor for debate on May 22. Conversely, House Bill 707 seeks to establish a regulatory framework for adult-use cannabis legalization, although it doesn’t outright legalize recreational cannabis. “This is a very simple bill,” said bill sponsor Rep. Edmond Jordan. “What it does…it is for the adult use of cannabis. It sets up the retail side with dispensaries and how we would do that.” If passed, it would permit adults over 21 to purchase one ounce of cannabis per day and pay $75 per year to cultivate up to six plants per adult, or 12 plants per household. House Bill 978 also would not legalize adult-use cannabis but sought to establish a foundation for legalization in the event that the federal government chose to legalize cannabis. “The bill does not legalize recreational marijuana,” said bill sponsor Rep. Candace Newell. “This is a regulation structure that I would like to see Louisiana put in place in preparation for having recreational marijuana legalized on the federal level or on the state level.” However, as of May 20 the bill was rejected in the House.

https://hightimes.com/

First Black, Woman-Owned Psilocybin Treatment Center Opens

A woman and minority-owned psilocybin treatment center in Oregon, the first of its kind, will soon open doors. It was co-founded by a mother and daughter team, Denise Taylor, a registered nurse (RN), and Laurie Thompson, an experienced meditator. Ashland Healing Center will provide relief to patrons for mental health conditions, PTSD, anxiety, depression, addiction, and end-of-life concerns, according to a May 21 announcement. During the journey each client is supported by a licensed Psilocybin Facilitator, and the focus is on psilocybin for personal transformation.  With the guidance of an experienced Psilocybin Facilitator, patrons are able to avoid unpleasant effects of the mushroom and its derivatives. “We partner with healthcare professionals to get the best results for our mutual clients and patients. Our services are of special interest to medical professionals, therapists, counselors, integrative health care practitioners, and anyone interested in improving mental health. We offer complimentary consultations to those interested in our services. We are also the only black-owned legal Psilocybin service center and are committed to improving mental health outcomes for the black community,” said Taylor. Taylor’s expertise as an RN helps the team to make better choices about potential interactions and safety issues. Psilocybin sessions go as follows, in four steps: The Oregon Psilocybin Advisory Board approved a limited number of recommendations. But Ashland Healing Center co-founders say that studies from John Hopkins, UC Davis, Yale, and NYU have demonstrated a broader span of potential for psilocybin-assisted therapy. “Psilocybin provides both medical and metaphysical/spiritual benefits,” said Thompson. “The results our clients experience are incredible. I’ve witnessed depression becoming love, relief from migraine headaches, spiritual experiences, release of intergenerational trauma, and physical healing. We are honored to offer these services and have served clients from across the nation. Ashland, Oregon, is accessible via the Rogue Valley International Medford Airport (code MFR).” As the direction of psilocybin sessions heavily relies on an individuals’ set and setting, much of the experience is self-directed. “Psilocybin treatment is not therapy,” the website states. “It is self-directed. Although success is often received with just one treatment, your intent and desire to change are of paramount importance. A willingness to begin working on that change before the experience and to continue after are key to your continued success. Safety and comfort are also important. We want you to work with a facilitator you trust in a safe place. As facilitators we will work with you to build trust.” In November 2020, Oregon voters  approved Measure 110, and the state officially became the first e to decriminalize hard drugs such as heroin or methamphetamine, and also legalized the use of psilocybin mushrooms for therapeutic use. By December 2022, the state was training facilitators to care for participants experiencing their psilocybin journey. It took until May 2023 to approve the first license, which belonged to EPIC Healing Eugene. A consult, which is free, typically lasts one hour. Beginning with Denver, Colorado, the first city to decriminalize psilocybin in 2019, other cities followed including Oakland and Santa Cruz, California; Washington, D.C.; Somerville, Cambridge and Northampton, Massachusetts; Seattle, Washington; and Detroit, Michigan. Oregon and Colorado moved to decriminalize psilocybin at the state level as well. Psilocybin is being explored for its role in helping people with eating disorders (ED), treatment-resistant depression and post-traumatic stress disorder (PTSD), and even stress due to childhood trauma. Psilocybin’s effects on ED, for instance, have been explored since the 1950s, and studies are zeroing in its ability to help us overcome treatment-resistant conditions like body dysmorphia, anorexia, or bulimia. Researchers Elena Koning and Elisa Brietzke are exploring the ways psilocybin can treat ED by its therapeutic benefits in combating rigid thought patterns. Koning, who is a doctoral student, recently wrote about her discoveries for PsyPost, explaining the reasoning behind her research. Koning mentioned that in the age of social media, EDs are becoming increasingly troublesome, and that new approaches to those types of disorders are needed. A recent study, “Psilocybin-Assisted Psychotherapy as a Potential Treatment for Eating Disorders: a Narrative Review of Preliminary Evidence,” was published online ahead of print for Trends Psychiatry. Another recent study, published recently in the Journal of Psychoactive Drugs, took a closer look at adverse childhood experiences as an “elevated risk for psychological distress,” specifically looking at how psilocybin may abate these effects. It was authored by researchers at Simon Fraser University, Athabasca University, University of British Columbia and University of Michigan. Researchers found that the use of psilocybin can help to ease psychological distress in people who had adverse experiences as children, indicating that psilocybin appeared to hold “particularly strong benefits to those with more severe childhood adversity.”

https://hightimes.com/

Travel on High

When you hear the phrase “cannabis tourism,” what comes to mind? A party bus with smoke billowing out of open windows? Scaling the side of a grassy hill to get a glimpse of the cannabis promised land? Perhaps hitting a joint and then gently descending into a child’s pose? All of these are correct. Cannabis-related tourism has evolved quite a bit since the early days of legalization. When Colorado voters passed adult use in 2012, people from all over the country flocked to the Centennial State to experience something they never had before—consuming cannabis legally. Early cannabis tourism experiences experimented with ideas, which commonly consisted of taking patrons to dispensaries where they could shop and then providing a safe space for them to consume their purchases, which was usually inside a tour bus or an outside venue. This brand of tourism exists in other markets as well, such as the craft beer market. People sign up for pub crawls where attendees can sample and purchase unique brews. Craft beer tourism also includes dinners with menus to highlight the flavors of the hops, tours of breweries where the beer is being made, as well as art gallery and music events where local, craft beers are showcased. There are even athletic events like Beer Mile, which incorporates both running and beer consumption in competition. So, what does that mean for the future of cannabis tourism? Certain regions in California are known for their wine culture. Napa, Sonoma, and Santa Barbara counties draw millions of people annually who enjoy leisurely strolls through the vineyards, artisan cheeses, and world-renowned wine. It’s a whole lifestyle. Similarly, Kentucky draws bourbon aficionados seeking the finest aged liquor. While still in its infancy, the cannabis sector of tourism has immense potential. The famed Emerald Triangle of northern California, including Mendocino, Humboldt, and Trinity counties, has a storied and rich history of cannabis cultivation and culture going back decades. Much of the production and cultivation of high-quality cannabis, as seen with today’s most popular strains, took place in those hills. While the stringent framework of cannabis legalization and the opinion of some who believe that cannabis grown outdoors is inferior (as if!) has taken its toll on the economic viability of production in this region, the history and stories are unmatched. Furthermore, the craft, legacy genetics, and regenerative cultivation techniques applied by farmers in the Emerald Triangle produce cannabinoid and terpene profiles that are complex, therapeutic, and unique to the region. (Here’s a tip: the next time you visit your local California dispensary, ask for something grown outdoors in the Emerald Triangle. You’re welcome.) Farm tours, farmers’ markets, and cannabis farm-to-table style dinners are just some of the offerings that could be featured in cannabis tourism. However, regulatory barriers like not allowing farmers to sell directly to the consumer or making it difficult to establish a tasting room in the small towns that dot Highway 101 have limited the realization of culture-driven cannabis tourism. Cannabis yoga was one of the first wellness activities to overtly pair wellness with consumption. Truthfully, many of us have been getting high before experiencing yoga, massages, meditation, and painting for as long as we can remember. However, the concept of marketing these activities with cannabis only surfaced after legalization. While the places where people can publicly smoke cannabis are limited, even in legal states, opportunities to openly consume at private facilities like yoga studios or outdoor venues make them a popular choice among the wellness crowd. As the normalization of cannabis use continues, these offerings may be less in the camp of cannabis tourism and more under the umbrella of wellness in general. Pairing and integrating cannabis with food is a perfect match, even when many of us, while in the throes of the munchies, have made some suspect food pairing decisions.  I recall one particular night when I was convinced that the peanut butter and easy cheese sandwich I had made was a culinary marvel. Still the fact remains that cannabis has the potential to enhance not only our appetites but also the experience of eating. Furthermore, like pairing food with wine, the flavors and aromas in cannabis can complement food as well, elevating both the cannabis, the meal, and you! There are two main types of cannabis dinners. The first pairs food with specific strains of cannabis to compliment the flavors and aromas of both and to guide the consumer through the meal in the context of the effects of cannabis. The second infuses meals with THC or other cannabinoids, which puts the focus on a high that evolves throughout the experience. This type of cannabis tourism is very popular among consumers. In the 2023 Consumer Survey from New Frontier Data, 73% of respondents said they would like to attend an infused dinner. Cannabis tourism once focused squarely on giving people who live in illegal states the chance to buy and consume cannabis without fear. As more states have continued to change their laws and more people have access to legal products, not only in their state but also in the neighboring ones, the offerings have shifted to include cannabis as a component of another activity, including cannabis in the context of dining as well as opportunities to experience and learn about legacy cannabis culture. There are many more emerging opportunities in the cannabis tourism space. To learn more about what’s trending, check out the Cannabis Travel Association International at cannabistravelassociation.org. This article was originally published in the March 2024 issue of High Times Magazine.

https://hightimes.com/

Quit Meth, Get Paid in Innovative California Recovery Program

A new California program incentivizes people using meth or cocaine with money if they can prove they are clean in an evidence-based system in which participants can earn incrementally more the longer they stay clean. Why? Because California is grappling with substance use disorder “crisis” with deaths from cocaine, meth, and other stimulants soaring in recent years. In 2021 for instance, 65% of drug-related overdose deaths involved stimulants, compared to 22% in 2011. The impulsive nature of stimulant cravings and addiction calls for alternative approaches. A Medi-Cal initiative called CalAIM provides social and behavioral health services, including addiction treatment to individuals in California . California Healthline reports that CalAIM provides people who use meth and cocaine with an incentive to quit habit-forming drugs that are difficult to kick on your own. Contingency Management (CM) is a program that provides motivational incentives to treat people who use stimulants like meth or cocaine, and support their path to recovery. It recognizes and reinforces individual positive behavioral change, and requires them to prove it with drug tests showing negative results for stimulants. “CM is the only treatment that has demonstrated robust outcomes for individuals living with stimulant use disorder, including reduction or cessation of drug use and longer retention in treatment,” the program states. “The Recovery Incentives Program increases access to new evidence-based treatments for Californians living with substance use disorder,” the program’s Fact Sheet states. “Starting in 2023, the program is available to members living with stimulant use disorder in participating counties, in outpatient, intensive outpatient, and Narcotic Treatment Program settings. As part of the program, eligible Medi-Cal members participate in a structured 24-week outpatient program, followed by at least six months of additional recovery support services. Participants meet with a trained contingency management coordinator twice weekly for the first 12 weeks of the program, then weekly for weeks 13 to 24 to complete a drug test. Participants receive a small gift card each time they test negative for stimulants and can earn up to $599 per year in incentives.” California is the first state in the country to receive federal approval of CM as a benefit in the Medicaid program through the CalAIM 1115 Demonstration. CM also tested other sources of funding. According to the state Department of Health Care Services, about 2,700 patients from 19 counties have enrolled in the program since April 2023. Quinn Coburn, 65, who is in the program, told California Healthline, “It’s that little something that’s holding me accountable.”  Coburn received $10 for each clean urine test he provided the first week of the program, and the pay increases in subsequent weeks: $11.50 per test in week two, $13 in week three—up to $26.50 per test. The program promises as much as $599 a year, and Coburn is proof that it’s doable: As of mid-May, Coburn had completed 20 weeks of clean drug tests and made $521.50. “The way stimulants work on the brain is different than how opiates or alcohol works on the brain,” said John Duff, lead program director at Common Goals, where Coburn receives treatment. “The reward system in the brain is more activated with amphetamine users, so getting $10 or $20 at a time is more enticing than sitting in group therapy.”. The average recovery rate for people suffering from meth addiction is around 37%, which is about equal to other physically addictive drugs such as cocaine, heroin, and prescription drugs. Cannabis is also being explored as a potential treatment to help reduce stimulant cravings. The fight against meth abuse is also taking place at the national level. In 2022, President Joe Biden signed legislation designed to address the rising scourge of meth abuse in the United States. The new law, titled the Methamphetamine Response Act, “requires the government to declare methamphetamine an ‘emerging drug threat’ and to develop a response plan specific to methamphetamine,” according to a press release. The bill had bipartisan support in the House of Representatives and Senate: its sponsors were Sens. Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa) and Reps. Scott Peters (D-Calif.) and John Curtis (R-Utah). According to a study from the National Institutes of Health, “overdose deaths involving methamphetamine nearly tripled from 2015 to 2019 among people ages 18-64 in the United States.” That study showed that the “number of people who reported using methamphetamine during this time did not increase as steeply, but the analysis found that populations with methamphetamine use disorder have become more diverse,” suggesting that “increases in higher-risk patterns of methamphetamine use, such as increases in methamphetamine use disorder, frequent use, and use of other drugs at the same time, may be contributing to the rise in overdose deaths.”

https://hightimes.com/

Study To Determine Impact of Cannabis on Driving Ability Delayed

An Australian trial that will investigate the impact of medical cannabis on driving ability won’t be finished until late 2025. The Guardian reports that Australian cannabis advocates are disappointed that the Victorian government appears to be delaying the study despite the issue being called a priority. In February 2023, then-state premier Daniel Andrews pushed to determine how cannabis impacts driving ability and said that the issue is a priority for the Victornian government. He estimated as many as 200,000 medicinal cannabis patients in Victoria are essentially restricted from driving.  That’s because THC can be detected in the body for weeks, if not months after consumption, meaning medicinal cannabis patients can essentially never drive without worry of driving while what authorities consider to be impaired. Victorian premier Jacinta Allan announced May 14 that Swinburne University of Technology in Melbourne, Australia has been selected to run the trial. The $4.9 million dollar trial ($3.26 million USD), to be completed over 18 months , will review about 70 medicinal cannabis patients’ ability to manage distractions and assess their performance behind the wheel, including steering, braking, and speed control on a dedicated track. “Just as we were the first state in the nation to introduce medicinal cannabis to support people with their medical illnesses, we are now moving to have this world-first trial to support and examine how it affects people as they’re out on this closed circuit driving track,” Allan said. Victoria became the first Australian state to legalize medical cannabis in 2016, but it remains illegal for individuals to drive with any trace of THC in their bloodstream. Legalise Cannabis MPs David Ettershank and Rachel Payne said they were disappointed in the timeline. “Jacinta Allan may be on a driving track today but I know she is intentionally ‘stalling’ on this decision,” Payne said. “In 2023, Dan Andrews promised an answer ‘in coming months’ followed by a guarantee to have it fixed by 2024. Now, with a new premier, it’s mid-2026 at best.” Ettershank suggested was “discriminating” against medicinal cannabis patients and the motives were political. What could change? Already in Tasmania, leaders established a medical defense if drivers are caught behind the wheel with THC in their system, as it can linger there for weeks or months. But roads minister, Melissa Horne said Tasmania had far fewer medicinal cannabis patients than Victoria. “At the heart of it, it is a basic human rights issue where we’ve got people out there who are taking a legally prescribed substance who cannot drive at the moment,” she said. While cannabis breathalyzers have emerged, made by several companies, there is currently very few, if any places in the world that has developed standardized cannabis impairment testing; All that exists are tests that can detect THC in the bloodstream, but that has little to do with current impairment. That could change quickly, however. Researchers in Australia have been determining the window that cannabis can impair driving performance. In one case, Thomas R Arkell, Danielle McCartney , Iain S McGregor, who are associated with The Lambert Initiative at the University of Sydney, studied the impact of cannabis on driving ability. They determined that cannabis can impair driving ability in the hours immediately after smoking, but the impairment ends well before THC metabolites are flushed from the bloodstream. “Patients using THC-containing products should avoid driving and other safety-sensitive tasks (e.g. operating machinery), particularly during initiation of treatment and in the hours immediately following each dose,” the authors wrote. “Patients may test positive for THC even if they do not feel impaired, and medical cannabis use does not currently exempt patients from mobile (roadside) drug testing and associated legal sanctions.” Hound Labs, based in Oakland, California, said in 2021 that market release is imminent for its Hound Marijuana Breathalyzer, which can detect the presence of THC molecules in the breath. “The first commercial units of the Hound Marijuana Breathalyzer will be in the hands of customers this spring,” Dr. Mike Lynn, an emergency room physician who is CEO and co-founder of Hound Labs, told High Times. “Production will ramp up throughout the rest of 2021.” The introduction of the Hound Breathalyzer could really shake things up for law enforcement, motorists, employees, employers, and medical cannabis patients. It’s different from other drug tests because Hound Labs reps say it can test whether the person is currently high, as measured by the presence of THC molecules in the breath. The developers of the Hound believe that THC molecules linger in the breath for up to four hours after smoking.  In the U.S., 12 states—Arizona, Delaware, Georgia, Indiana, Iowa, Michigan, Oklahoma, Pennsylvania, Rhode Island, South Dakota, Utah and Wisconsin—have zero-tolerance laws for certain drugs including THC.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.